𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Intracellular presence of insulin and its phosphorylated receptor in non-small cell lung cancer

✍ Scribed by Stefano Mattarocci; Claudia Abbruzzese; Anna M. Mileo; Paolo Visca; Barbara Antoniani; Gabriele Alessandrini; Francesco Facciolo; Armando Felsani; Razvan T. Radulescu; Marco G. Paggi

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
236 KB
Volume
221
Category
Article
ISSN
0021-9541

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Insulin has been known for a long time to influence the growth and differentiation of normal and transformed cells. In order to delineate the role of insulin specifically in non‐small cell lung cancer (NSCLC), we have now searched by immunohistochemistry (IHC) for the presence of insulin in NSCLC samples. Among the 112 samples we studied, 30 were found to contain insulin, which was detected in the form of intracytoplasmic granula. Moreover, its expression significantly correlated with (a) the morphological/histopathological subtype of NSCLC, being more frequent in adenocarcinomas; (b) the grade of tumor differentiation, displaying an increase in low‐grade carcinomas; (c) tumor size, occurring predominantly in smaller tumors; (d) the presence of phosphorylated, activated insulin receptor; (e) the median patient age, being present in relatively younger individuals. Furthermore and interestingly, surrounding atypical adenomatous hyperplastic areas and normal alveolar pneumocytes scored insulin‐positive in some of the insulin‐negative tumors. In addition, PCR exploration for insulin transcripts in some samples positive for immunoreactive insulin was negative, indicating a possibly exogenous origin for the intracellular insulin in our NSCLC cohort. Taken together, our data suggest that an intracellular insulin activity is important for the progression of low‐grade human lung adenocarcinomas. J. Cell. Physiol. 221: 766–770, 2009. © 2009 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Genomewide loss of heterozygosity and it
Genomewide loss of heterozygosity and its clinical associations in non small cell lung cancer
✍ Ruo-Chia Tseng; Jer-Wei Chang; Feng-Jen Hsien; Ya-Hui Chang; Chin-Fu Hsiao; Jung 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 462 KB 👁 1 views

## Abstract We extensively allelotyped a panel of 71 microdissected primary surgically resected non small cell lung cancer (NSCLC) tumors to identify chromosomal regions that are likely to contain tumor suppressor genes (TSGs) or associated with clinicopathologic and prognostic effects. Loss of het

Identification of TDE2 gene and its expr
Identification of TDE2 gene and its expression in non-small cell lung cancer
✍ Audrey Player; John Gillespie; Takeshi Fujii; Junya Fukuoka; Tatiana Dracheva; D 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 336 KB 👁 2 views

## Abstract __TDE2__, a gene with sequence similarity to the mouse testicular tumor‐differentially‐expressed (__Tde1__/__MUSTETU__) gene, was identified by serial analysis of gene expression (SAGE) in nonsmall cell lung cancers (NSCLC). Here we characterized the __TDE2__ gene and determined its tra

Gender difference in estrogen receptor a
Gender difference in estrogen receptor alpha promoter hypermethylation and its prognostic value in non-small cell lung cancer
✍ Ji-Ching Lai; Ya-Wen Cheng; Hui-Ling Chiou; Ming-Fang Wu; Chin-Yi Chen; Huei Lee 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 244 KB

## Abstract It has been documented that estrogen receptor (ER) transcription silencing due to hypermethylation is linked to the tumor progression of breast, uterine and prostate cancers. Additionally, ER hypermethylation in lung tumors has been associated with the exposure of specific carcinogens i

Aberrant methylation of TMS1 in small ce
Aberrant methylation of TMS1 in small cell, non small cell lung cancer and breast cancer
✍ Arvind Virmani; Asha Rathi; Kenji Sugio; Ubaradka G. Sathyanarayana; Shinichi To 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 320 KB 👁 2 views

## Abstract __TMS1__ (target of methylation‐induced silencing) is a CpG island‐associated gene that functions in the regulation of apoptosis and encodes a caspase recruitment domain, a recently described motif found in apoptotic signaling molecules. Recent evidence suggests that silencing of genes

RASSF1A gene inactivation in non-small c
RASSF1A gene inactivation in non-small cell lung cancer and its clinical implication
✍ Hideki Endoh; Yasushi Yatabe; Shigeki Shimizu; Kohei Tajima; Hiroyuki Kuwano; Ta 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 227 KB 👁 1 views

## Abstract Methylation‐associated inactivation of __RASSF1__, a putative tumor suppressor identified at 3p21.3, is reported in several cancers. We examined __RASSF1__ in non‐small lung cancer (NSCLC) to search for clinical implications. RT‐PCR analysis showed no expression of __RASSF1A__ in 12 of